酸通过抑制Akt1/NF-κB信号通路来缓解DNCB诱导的亚托皮炎
Wenkai Nie1, Xuan Zhao1, Yan Zhang1
1School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
European journal of pharmacology
|March 21, 2025
概括
酸 (CGA) 通过减少炎症和抑制Akt1/NF-κB通路,有效治疗亚托皮炎 (AD). 这种天然化合物显示出作为阿尔茨海默病治疗剂的前景.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 无氧性皮肤炎 (AD) 是一种常见的炎症性皮肤疾病,影响生活质量.
- 酸 (CGA) 是一种植物性多,具有抗炎性质.
- 在AD中CGA的治疗潜力和机制需要进一步研究.
研究的目的:
- 评估CGA在皮炎小鼠模型中的疗效.
- 为了阐明CGA在AD中的抗炎机制.
主要方法:
- 使用2,4-丁基 (DNCB) 诱导了一种亚托皮性皮肤炎小鼠模型.
- 通过细胞因子水平 (IL-1β,IL-6) 和信号通路 (PI3K/Akt,NF-κB) 的西部斑点来评估抗炎作用.
- 用分子对接来预测CGA与Akt1的相互作用.
主要成果:
- CGA治疗显著降低了皮肤炎的严重程度,脏指数,表皮厚度和炎症细胞透.
- CGA逆转了IgE,组胺和促炎细胞因子 (TNF-α,IL-1β,IL-6,IL-8) 的增加.
- CGA抑制了PI3K/Akt和NF-κB信号通路,Akt1被确定为潜在的分子标.
结论:
- 酸在亚托皮性皮肤炎中表现出显著的治疗作用.
- CGA通过抑制Akt1/NF-κB信号通路而起作用.
- CGA具有作为治疗亚托皮性皮肤炎的天然治疗剂的潜力.
关键词:
这就是为什么Akt1 Akt1 Akt1 Akt1 Akt1抗炎药物 抗炎药物 抗炎药物亚托邦性皮肤炎 (Atopic Dermatitis) 是一种不良的疾病.基酸是一种基酸.分子对接是分子对接.更多相关视频
06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
9.6K
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
24.5K
相关概念视频
01:12Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.0K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.0K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
145
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
145